Marco HEOR enables hospital pharmacy and therapeutics committees to evaluate the adoption of new health technologies and high-cost treatments in a structured way, based on real-world evidence and HTA standards.
Some answers to questions we often receive
Yes. Marco HEOR is designed to support health technology evaluation committees, generating structured reports that synthesize available evidence for each technology under review.
Yes. Marco HEOR generates structured, exportable reports in standard formats ready for presentation to the evaluation committee.
Yes. Having structured, evidence-based evaluations allows the hospital to argue with precise data on comparative efficacy and available alternatives, strengthening its negotiating position in high-impact procurement contracts.
Marco HEOR includes synthesis of published cost-effectiveness evidence and can structure parameters for hospital-specific analyses.
Marco HEOR drastically reduces report generation time. An evaluation that would manually require weeks can be completed in days, with full traceability of sources and criteria used, ready for committee presentation.
Yes. University hospitals can use Marco HEOR for pharmacy committee evaluations, to support pharmacoeconomic research, and for the training of residents and fellows in HEOR methodology.
Hospitals don't always have structured methodologies to evaluate the incorporation of new high-cost treatments in a rigorous and comparable way.
